{"id":4613,"date":"2023-07-11T14:53:43","date_gmt":"2023-07-11T14:53:43","guid":{"rendered":"https:\/\/integratedcarejournal.com\/?p=4613"},"modified":"2023-07-28T15:11:33","modified_gmt":"2023-07-28T15:11:33","slug":"major-agreement-deliver-new-cancer-vaccine-trials","status":"publish","type":"post","link":"https:\/\/integratedcarejournal.com\/major-agreement-deliver-new-cancer-vaccine-trials\/","title":{"rendered":"Major agreement to deliver new cancer vaccine trials"},"content":{"rendered":"
The Government has announced the signing of a major agreement<\/a> with pharmaceutical company BioNTech, to deliver precision cancer medicine to 10,000 patients by 2030, supported by NHSE\u2019s Cancer Vaccine Launch Pad and new laboratories to be set up by BioNTech around England. The agreement brings the NHS a step closer to transforming cancer treatment for patients, using the technology first used during the pandemic against COVID to create personalised cancer immunotherapy options.<\/p>\n